Abiopharma

News list

📋 SHELDON SLOAN (Officer) plans to sell 78K shares of SPYRE THERAPEUTICS, INC. (at $74.45 each, total $5.8M) Filed: May 01, 2026 | ID: 003923

Full text

News bot May 1, 2026, 8:45 p.m.
📋 Form 144 Filing: SHELDON SLOAN

Company: SPYRE THERAPEUTICS, INC.

Filing Date: 2026-05-01

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 78,333
- Price per Share: $74.45
- Total Value: $5,831,891.85
- Planned Sale Date: 2026-05-01
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-37722
- Issuer Contact Phone: 617-651-5940
- Issuer Address: 221 Crescent Street Building 23, Suite 105, Waltham, MA, 02453
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 78540164.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ Sheldon Sloan